Rising Prevalence of Metabolic Dysfunction - Associated Steatotic Liver Disease in an urban South Indian screening cohort: a Retrospective Cross-sectional Study.
PURPOSE Metabolic dysfunction-associated steatotic liver disease (MASLD), redefined in 2023 from non-alcoholic fatty liver disease, is highly prevalent globally, but population-level data using 2023 AASLD criteria and FibroScan-based assessment remain scarce in South Asia, particularly among asymptomatic adults undergo...